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Wepresenta15-year-oldfemalepatientwithmedullarythyroidcarcinoma,marfanoidhabitus,andmucosalganglioneuromatosis.
Our case had a RET protooncogene mutation ser836 polymorphism in exon 14 and ser904 polymorphism in exon 15. Our patient
is thought to be atypical MEN2B due to the absence of M918T or A883F mutations. Chilaiditi sign is an incidental radiographic
ﬁnding of a usually asymptomatic condition in which a part of intestine is located between the liver and diaphragm; however,
the term “Chilaiditi syndrome” is used for symptomatic hepatodiaphragmatic interposition. The patient had no symptoms
as abdominal pain, constipation, diarrhea, or emesis. Incidentally, Chilaiditi sign was diagnosed with chest radiograph and
thoracoabdominal CT. Our case is the ﬁrst in the literature indicating the coexistence of Chilaiditi sign and MEN2B.
1.Introduction
Multiple endocrine neoplasia type 2B (MEN2B) is a rare
autosomal dominant syndrome characterized by medullary
thyroid carcinoma (MTC), pheochromocytoma, marfanoid
habitus, and mucosal/intestinal ganglioneuromatosis. Gas-
trointestinal ganglioneuromatosis is the predominant etiol-
ogy of gastrointestinal symptoms in patients with MEN2B
[1]. Chilaiditi sign is an incidental radiographic ﬁnding of a
usually asymptomatic condition in which a part of intestine
is located between the liver and diaphragm; however, the
term “Chilaiditi syndrome” is used for symptomatic hep-
atodiaphragmatic interposition [2]. We detected Chilaiditi
sign on chest radiograph and thoracoabdominal CT of our
patientwithMEN2B.Intheliterature,Chilaiditisignwasnot
previously described in MEN2B. Our case is the ﬁrst case in
which MEN2B is accompanied by Chilaiditi sign.
2. Case Presentation
A 15-year-old female was admitted with complaint of pain-
less swelling of the neck. Physical examination ﬁndings were
marfanoid habitus, bilateral palpable thyroid nodules, and
numerous yellowish-white, sessile, painless nodules on the
tongue (Figure 1). Laboratory ﬁndings are TSH 2.29mU/mL
(reference range 0.27–4.2mU/mL), free T4 1.30ng/dL (ref-
erence range 0.93–1.7ng/dL), free T3 3.42pg/mL (ref-
erence range 1.8–4.6pg/mL), antithyroglobulin antibody
15.29IU/mL (reference range 0–115IU/mL), parathor-
mone 53.95pg/mL (reference range 15–65pg/mL), calcit-
onin 528pg/mL (reference range 0–11.5pg/mL), and CEA
29.2mcg/L (reference range 0–2.5mcg/L). Ultrasound imag-
ing of the thyroid gland revealed bilateral, hyperecogenic
nodules containing foci of microcalciﬁcation with the larg-
est diameter of 23mm. The patient was thought to be MTC.2 Case Reports in Endocrinology
Figure 1: Mucosal ganglioneuromatosis.
Pheochromocytoma was excluded by laboratory ﬁndings
including urinary VMA, metanephrine, and normetaneph-
rine within normal range. The patient underwent total
thyroidectomyandcentrallymphnodedissection.Inthesur-
gical specimen, tumor cell clusters were observed 2.3cm at
theleftlobe,1cmattherightlobe.Metastasiswasdetectedin
7 of 9 nodes resected. The immunohistochemical staining of
tumorsectionsrevealeddiﬀusepositivestainingwithchrom-
ogranin, NSE, calcitonin, CEA, synaptophysin, and keratin.
There was no staining with thyroglobulin. The deposition
of amyloid which was stained with crystal violet and congo
red was detected in some foci. Spindle cells showed insular
and follicular growth pattern characteristics (Figure 2). Tests
for RET protooncogene in exon 14 (ser836 polymorphism)
and exon 15 (ser904 polymorphism) were positive, but
exons 10, 11, 13, and 16 were negative. RET protooncogene
examination of the patient’s family members showed that
father and brother had ser904 polymorphism in exon 15;
exon 16 was negative. There was no evidence of metastasis in
the postoperative evaluation including cervical ultrasound,
thoracic and abdominal CT, PET/CT, and radionuclide bone
scan. Serum calcitonin levels were monitored periodically.
Chest radiograph and thoracoabdominal CT showed colonic
interposition between the liver and right hemidiaphragm
(Figures 3 and 4). The patient had no symptoms as abdomi-
nal pain, constipation, diarrhea or emesis. Chilaiditi sign was
diagnosed incidentally. Rectoscopy was performed because
the patient did not admit colonoscopy. Rectal biopsy was
normal and there was no mucosal ganglioneuromatosis.
3. Discussion
MEN2B typically manifests in the ﬁrst year of life with
mucosal neuromas, intestinal ganglioneuromas, and mar-
fanoid habitus as a result of de novo mutation [3]. The
prevalence of MEN2 has been estimated at 1:35000 [4].
MEN2B generates <10% of MEN2 syndromes with a higher
mortality rate [5]. All MEN2 variants are based on germline
mutation in the RET gene and MEN2B is the most aggressive
of these variants [6]. In MEN2B patients, ≥95% of cases
present the M918T mutation in exon 16, 2%-3% of cases
presenttheA883Fmutationinexon15[7,8].RET mutations
at codons 805, 806, and 904 in cis conﬁguration with
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Figure 2: The immunohistochemical staining of tumor sections
(a) Hematoxylin and eosin reveal insular and follicular growth
pattern characteristics of spindle cells. (b) and (c) The deposition
of amyloid is detected in some foci with crystal violet and congo
red. (d) The staining with calcitonin.
the P.V804M mutation have also been reported [9–11].
single-nucleotide Polymorphisms (SNPs) within the RET
oncogene have been reported (G691S, L769L, S836S, and
S904S), and the modifying role of the clinical phenotype
of MEN2 has been discussed [3, 12]. Our case had a RET
protooncogene mutation ser836 polymorphism in exon 14
and ser904 polymorphism in exon 15. Our patient is thoughtCase Reports in Endocrinology 3
Figure 3: Colonic interposition between the liver and right
hemidiaphragm.
to be atypical MEN2B due to the absence of M918T or
A883F mutations. Gastrointestinal ganglioneuromatosis is
the predominant etiology of gastrointestinal symptoms in
patients with MEN2B, resulting in bowel tone decrease,
distention, segmental dilatation, and megacolon. The most
reported symptoms were constipation and intermittent
diarrhea [1, 13]. Gastrointestinal symptoms usually manifest
in infancy and present before symptoms of extraintestinal
endocrine abnormalities [1, 13–15]. Chilaiditi sign is an
incidental radiographic ﬁnding of a usually asymptomatic
condition in which a part of intestine is located between
the liver and diaphragm; however, the term “Chilaiditi
syndrome” is used for symptomatic hepatodiaphragmatic
interposition [2]. It was ﬁrst described by Demetrious
Chilaiditi in 1910. The incidence of this syndrome is
0.025–0.28% [16]. Megacolon, abnormal colonic motility,
eventration of diaphragm, phrenic nerve injury, cirrhosis,
a congenital etiology, laxity of the suspensory ligaments,
obesity, and previous surgery are possible factors that may
lead to this syndrome [2]. Nausea, vomiting, constipation,
abdominal distention, and pain are gastrointestinal symp-
tomsoftheChilaiditisyndrome.Respiratorydistress,cardiac
arrhythmia, acute intestinal obstruction, and volvulus of
the colon are possible complications [17]. Conservative
management includes bed rest, nasogastric and/or rectal
decompression, and liquid replacement. Surgery may be
required in patients with persistent pain, refractory ileus,
colonic volvulus, or bowel ischemia [17, 18]. We wanted
to emphasize the coexistence of MEN2B and Chilaiditi
syndrome in diﬀerential diagnosis due to the similarity of
symptoms that can be seen in Chilaiditi syndrome and
MEN2B related to gastrointestinal ganglioneuromatosis. In
our patient, gastrointestinal ganglioneuromatosis was not
considered because she had no gastrointestinal complaints.
Chilaiditi sign has not been described in patients with
MEN2B. Also, our case is the ﬁrst in the literature indicating
the coexistence of Chilaiditi sign and MEN2B.
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Figure 4: Colonic interposition between the liver and right hemidi-
aphragm. (a) and (b) The colonic segment which displaced the liver
towards the left side wall of the abdomen. (c) Hydropic gallbladder
and normal adrenal glands. (d) The head of pancreas is normal.
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